ÂÜÀòÂÒÂ×

Benjamin Navon is an experienced communications professional with a focus on corporate communications in the pharmaceutical and biotech sectors. Currently serving as Director of Corporate Communications at Orchard Therapeutics since 2021, Benjamin has previously held leadership positions at W2O Group, including Group Director and Senior Account Director, where responsibilities included managing large client accounts and executing integrated communications campaigns. At WE Communications, as Account Director, Benjamin oversaw high-profile projects and provided strategic guidance on media strategies and crisis communications. Earlier roles at MSLGROUP and LaVoie Group involved managing public relations programs and executing outreach on behalf of various life sciences companies. Benjamin began a career in journalism as a reporter intern at Institutional Investor and holds a Bachelor of Science degree in Communications from Salem State University.